AAV Gene Therapy CRO Services & Assays - Accelevir

Accelevir is a Maryland-based biotechnology company and CLIA-certified central lab CRO specializing in ultra-sensitive molecular and immunological analytics for infectious diseases, cell and gene therapies, oncology, and inflammatory diseases.

Core Capabilities

Molecular Analytics

• Ultra-sensitive molecular analysis (qPCR, dPCR) with low input and scarce samples
• Targeted short- and long-read sequencing
• Vector biodistribution and shedding analysis
• Custom primary and multi-species assay design

Immunology & Cell-Based Services

• Custom immunology and cell-based assays
• Flow cytometry, cytokine profiling, and ELISpot
• Custom flow cytometry and functional immunology assays
• Deep immune phenotyping and cell-mediated cytotoxicity assessment
• PBMC processing and functional validation services

Virology & Gene Editing

• Functional virology (HIV phenotyping, bulk outgrowth)
• Plaque assays, focus-forming assays, and neutralization titer assays
• CRISPR and gene editing on- and off-target assays
• Vector copy number and integration site analysis

Integrated Workflows

• Pioneering immunovirology workflows integrating advanced virology and immunology analytics
• Simultaneous viral load, vector, and immune response measurements from single samples
• End-to-end molecular, cellular, and immunological functional capabilities for clinical trials

Infrastructure

CLIA-certified workflow with BSL-2+ facility. Combines cutting-edge molecular technologies including digital PCR, single target culture techniques, high-fidelity sequencing, and data-driven analytics. Operates with strong scientific focus, operational discipline, and customer-focused ethos.